Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
Julien Andréani, Marion Le Bideau, Isabelle Duflot, et al.
Microbial Pathogenesis (2020) Vol. 145, pp. 104228-104228
Open Access | Times Cited: 303

Showing 26-50 of 303 citing articles:

Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation
Mathieu Gendrot, Julien Andréani, Manon Boxberger, et al.
Travel Medicine and Infectious Disease (2020) Vol. 37, pp. 101873-101873
Open Access | Times Cited: 99
COVID-19, cytokines, inflammation, and spices: How are they related?
Ajaikumar B. Kunnumakkara, Varsha Rana, Parama Dey, et al.
Life Sciences (2021) Vol. 284, pp. 119201-119201
Open Access | Times Cited: 95
COVID-19 challenges and its therapeutics
Sabi Ur Rehman, Shaheed Ur Rehman, Hye Hyun Yoo
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112015-112015
Open Access | Times Cited: 92
Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019
Pankaj Bansal, Amandeep Goyal, Austin Cusick, et al.
Annals of Medicine (2020) Vol. 53, Iss. 1, pp. 117-134
Open Access | Times Cited: 91
In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
Mathieu Gendrot, Julien Andréani, Priscilla Jardot, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5064-5064
Open Access | Times Cited: 87
An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19)
Saibal Das, Subhrojyoti Bhowmick, Sayali Tiwari, et al.
Clinical Drug Investigation (2020) Vol. 40, Iss. 7, pp. 591-601
Open Access | Times Cited: 85
COVID-19 Therapeutic Options Under Investigation
Malak Kaddoura, Malak Al Ibrahim, Ghina Hijazi, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 83
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
Timothy S.C. Hinks, Lucy Cureton, Ruth Knight, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 10, pp. 1130-1140
Open Access | Times Cited: 79
Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
Xia Xiao, Conghui Wang, De Chang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 77
Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world
Matthieu Million, Philippe Gautret, Philippe Colson, et al.
New Microbes and New Infections (2020) Vol. 38, pp. 100709-100709
Open Access | Times Cited: 71
Canonical and Noncanonical Autophagy as Potential Targets for COVID-19
Melissa Belló-Pérez, Isabel Sola, Beatriz Novoa, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1619-1619
Open Access | Times Cited: 70
Binding and drug displacement study of colchicine and bovine serum albumin in presence of azithromycin using multispectroscopic techniques and molecular dynamic simulation
Tanveer A. Wani, Ahmed H. Bakheit, Abdulrahman A. Al‐Majed, et al.
Journal of Molecular Liquids (2021) Vol. 333, pp. 115934-115934
Open Access | Times Cited: 67
Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19)
Monic Andrew, G. Jayaraman
Carbohydrate Research (2021) Vol. 505, pp. 108326-108326
Open Access | Times Cited: 67
COVID‐19: A systematic review and update on prevention, diagnosis, and treatment
Hooman Aghamirza Moghim Aliabadi, Reza Eivazzadeh‐Keihan, Arezoo Beig Parikhani, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 43
Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020
Nikolina Bogdanić, Loris Močibob, Toni Vidović, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0263437-e0263437
Open Access | Times Cited: 37
The Strengths of Scanning Electron Microscopy in Deciphering SARS-CoV-2 Infectious Cycle
Djamal Brahim Belhaouari, Anthony Fontanini, Jean‐Pierre Baudoin, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 65
Methylene blue inhibits replication of SARS-CoV-2 in vitro
Mathieu Gendrot, Julien Andréani, Isabelle Duflot, et al.
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 6, pp. 106202-106202
Open Access | Times Cited: 65
Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials
Rami A. Al‐Horani, Srabani Kar, Kholoud F. Aliter
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5224-5224
Open Access | Times Cited: 58
Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
Nabab Khan, Xuesong Chen, Jonathan D. Geiger
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 55
Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19
Jacques Fantini, Henri Chahinian, Nouara Yahi
Biochemical and Biophysical Research Communications (2020) Vol. 538, pp. 132-136
Open Access | Times Cited: 54
Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
Bianza Moïse Bakadia, Feng He, Tiatou Souho, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 111008-111008
Open Access | Times Cited: 53
Should azithromycin be used to treat COVID-19? A rapid review
Oghenekome Gbinigie, Kerstin Frie
BJGP Open (2020) Vol. 4, Iss. 2, pp. bjgpopen20X101094-bjgpopen20X101094
Open Access | Times Cited: 51
Repurposing of antibiotics for clinical management of COVID-19: a narrative review
Abdourahamane Yacouba, Ahmed Olowo‐okere, Ismaeel Yunusa
Annals of Clinical Microbiology and Antimicrobials (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 51
Drug repurposing for COVID-19: a potential threat of self-medication and controlling measures
Tauqeer Hussain Mallhi, Yusra Habib Khan, Nasser Hadal Alotaibi, et al.
Postgraduate Medical Journal (2020) Vol. 97, Iss. 1153, pp. 742-743
Open Access | Times Cited: 50
Natural and Synthetic Drugs as Potential Treatment for Coronavirus Disease 2019 (COVID-2019)
Saba Farooq, Zainab Ngaini
Chemistry Africa (2020) Vol. 4, Iss. 1, pp. 1-13
Open Access | Times Cited: 50

Scroll to top